Co-Sponsored with
Preliminary Program
Registration is now open!
View the NBC Facebook Page
Questions? Contact the AAPS office:
Emily Allsopp
Meetings Manager
2107 Wilson Blvd.
Suite 700
Arlington, VA 22201
Phone: (703) 248-4783
Email: allsoppe@aaps.org
Dear Colleagues,
It is my pleasure to announce that the 2010 AAPS National Biotechnology Conference will be taking place May 16 –19, 2010 at the Hilton San Francisco Union Square in San Francisco, California. Attendees will have access to one full week of educational programming during this annual event devoted to advancing health through innovations in biotherapeutics.
The week begins with the AAPS Workshop – Strategies to Address Therapeutic Protein Drug Interactions during Clinical Development, taking place May 15 –16. Also, the two-day 2010 AAPS Immunogenicity Training Course: Development of Ligand Binding Analytical Methods to Support Immunogenicity Testing Theoretical to Practical Considerations will be taking place May 15 –16. And, the AAPS Short Course, Introduction to the Challenges of a New AAPS Focus Group: Therapeutic Protein Immunogenicity, will be taking place May 16. The week then proceeds through the full 2010 AAPS National Biotechnology Conference programming. The 2010 programming consists of a Plenary Session, Symposia, Roundtables, Posters, and Hot Topics. The week concludes with two short courses. Additionally, an Exposition Hall will be hosting major companies.
If you have any questions about the program or registration procedures, please contact the AAPS office at +1 703-243-2800, or, you can send an email to meetings@aaps.org. The 2010 AAPS National Biotechnology Conference is designed to provide a complete educational event allowing each and every attendee the ability to customize their experience with the goal of advancing health through innovations in biotherapeutics. See you in San Francisco!
Sincerely,
Danny Shen, Ph.D.
AAPS President
IMPORTANT DATES
- Travelship Application Deadline: March 5, 2010
MEDIA
To register as press or to schedule an interview with a speaker, please email Joseph Catapano or call (703) 248-4772.
Programming Committee
Amita Joshi, Ph.D., Genentech, Chair
Binodh S. DeSilva, Ph.D., Amgen, Inc., Chair-elect
Andrew M. Vick, Ph.D., Seventh Wave Laboratories LLC, Past Chair
Karoline B. Bechtold-Peters, Ph.D, Boehringer Ingelheim Pharma GmbH & Co. KG
Steve Lowes, Ph.D., Advion BioServices Inc.
Feroz Jameel, Amgen, Inc.
Lavinia Marina Lewis, Ph.D., Pfizer Inc.
Steven W. Martin, Ph.D., Pfizer Global Research and Development
Giovanni M. Pauletti, Ph.D., University of Cincinnati
Mark C. Peterson, Ph.D., Biogen Idec
Nanda Subbarao, Ph.D., Biologics Consulting Group
Keith Webber, Ph.D., U.S. Food and Drug Administration
Chang-Guo Zhan, Ph.D., University of Kentucky